SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NTEG- Bloodless Glucose Monitor
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tevyah who wrote (35)9/29/1997 10:11:00 PM
From: Stratajema   of 176
 
Ken. Integ is a thinly traded stock and so its price can be easily moved up or down. The move from $6.25 to $9.50 was just as easy as the move back down into the $5 dollar range.

I really have no direct explanation for the sell off. Maybe it was short-sellers pouncing on the stock to show a quick profit this quarter, or maybe somebody knows something we don't know yet. All I have to rely on during these rollercoaster rides is my own research and my investment time horizon. I think there are still a lot of weak holders around after the spike up to $9.50 in June under heavy volume.

I am building a position in this stock in increments. So I try to judge the progress Integ has made relative to the stock price, to decide if I should buy my next increment. Perhaps more progress can be judged after Integ announces 3rd quarter results in October which is the timing for my next increment.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News